Canine influenza virus replicates in alveolar macrophages and induces TNF-α

Veterinary Pathology

Volumn 46, Issue 6, 2009, Pages 1187-1196

  Powe, J R ^a   Castleman, W L ^a  

^a University of Florida College of Veterinary Medicine   (United States)

Author keywords

Alveolar macrophages; Canine influenza virus; H3N8 subtype; Influenza A virus; Tumor necrosis factor alpha

Indexed keywords

ANIMALIA; CANIS FAMILIARIS; INFLUENZA A VIRUS; INFLUENZAVIRUS A; ORTHOMYXOVIRIDAE;

MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; CELL DEATH; DOG; GENE EXPRESSION REGULATION; GENETICS; INFLUENZA VIRUS A H3N8; LUNG ALVEOLUS MACROPHAGE; METABOLISM; PHYSIOLOGY; VIROLOGY; VIRUS REPLICATION;

ANIMALS; CELL DEATH; DOGS; GENE EXPRESSION REGULATION; INFLUENZA A VIRUS, H3N8 SUBTYPE; MACROPHAGES, ALVEOLAR; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; VIRUS REPLICATION;

EID: 75649151716     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1354/vp.08-VP-0229-P-FL     Document Type: Article

References (43)

1. Abraham LJ, Kroeger KM: Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukoc Biol 66:562-566, 1999
2. Abramson JS, Mills EL, Giebink GS, Quie PG: Depression of monocyte and polymorphonuclear leukocyte oxidative metabolism and bactericidal capacity by influenza A virus. Infect Immun 35:350-355, 1982
3. Bender A, Sprenger H, Gong JH, Henke A, Bolte G, Spengler HP, Nain M, Gemsa D: The potentiating effect of LPS on tumor necrosis factor-alpha production by influenza A virus-infected macro-phages. Immunobiology 187:357-371, 1993
4. Bueno R, Mello MN, Menezes CA, Dutra WO, Santos RL: Phenotypic, functional, and quantitative characterization of canine peripheral blood monocyte-derived macrophages. Mem Inst Oswaldo Cruz 100:521-524, 2005
5. Chang EY, Guo B, Doyle SE, Cheng G: Cutting edge: involvement of the type I IFN production and signaling pathway in lipopolysaccharide-induced IL-10 production. J Immunol 178:6705-6709, 2007
6. Chen W, Calvo PA, Malide D, Gibbs J, Schubert U, Bacik I, Basta S, O'Neill R, Schickli J, Palese P, Henklein P, Bennink JR, Yewdell JW: A novel influenza A virus mitochondrial protein that induces cell death. Nat Med 7:1306-1312, 2001
7. Cheung CY, Poon LL, Lau AS, Luk W, Lau YL, Shortridge KF, Gordon S, Guan Y, Peiris JS: Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 360:1831-1837, 2002
8. Coleman JR: The PB1-F2 protein of Influenza A virus: increasing pathogenicity by disrupting alveolar macrophages. Virol J 4:9, 2007
9. Couper KN, Blount DG, Riley EM: IL-10: the master regulator of immunity to infection. J Immunol 180: 5771-5777, 2008
10. Crawford PC, Dubovi EJ, Castleman WL, Stephenson I, Gibbs EP, Chen L, Smith C, Hill RC, Ferro P, Pompey J, Bright RA, Medina MJ, Johnson CM, Olsen CW, Cox NJ, Klimov AI, Katz JM, Donis RO: Transmission of equine influenza virus to dogs. Science 310:482-485, 2005
11. Dubovi EJ, Njaa BL: Canine influenza. Vet Clin North Am Small Anim Pract 38:827-835, 2008
12. Fesq H, Bacher M, Nain M, Gemsa D: Programmed cell death (apoptosis) in human monocytes infected by influenza A virus. Immunobiology 190:175-182, 1994
13. Fujiwara S, Yasunaga S, Iwabuchi S, Masuda K, Ohno K, Tsujimoto H: Cytokine profiles of peripheral blood mononuclear cells from dogs experimentally sensitized to Japanese cedar pollen. Vet Immunol Immunopathol 93:9-20, 2003
14. Hawthorne JD, Albrecht P: Sensitive plaque neutralization assay for parainfluenza virus types 1, 2, and 3 and respiratory syncytial virus. J Clin Microbiol 13:730-737, 1981
15. Headley AS, Tolley E, Meduri GU: Infections and the inflammatory response in acute respiratory distress syndrome. Chest 111:1306-1321, 1997
16. Ho CK, Babiuk LA: Long-term culture of canine peripheral blood monocytes in vitro. Can J Comp Med 43:223-228, 1979
17. Hofmann P, Sprenger H, Kaufmann A, Bender A, Hasse C, Nain M, Gemsa D: Susceptibility of mononuclear phagocytes to influenza A virus infection and possible role in the antiviral response. J Leukoc Biol 61:408-414, 1997
18. Julkunen I, Sareneva T, Pirhonen J, Ronni T, Melen K, Matikainen S: Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression. Cytokine Growth Factor Rev 12:171-180, 2001
19. Kim HM, Lee YW, Lee KJ, Kim HS, Cho SW, van Rooijen N, Guan Y, Seo SH: Alveolar macrophages are indispensable for controlling influenza viruses in lungs of pigs. J Virol 82:4265-4274, 2008
20. Lamb R, Krug RM: Orthomyxoviridae: the viruses and their replication. In: Fields Virology, ed. Knipe D, Howley P, Griffin DE, Lamb R, Martin M, Roizman B, Straus SE, 4th ed., pp. 1487-1531. Lippincott Williams & Wilkins, Philadelphia, PA, 2001
21. Lee DC, Cheung CY, Law AH, Mok CK, Peiris M, Lau AS: p38 mitogen-activated protein kinasedependent hyperinduction of tumor necrosis factor alpha expression in response to avian influenza virus H5N1. J Virol 79:10147-10154, 2005
22. Lowy RJ, Dimitrov DS: Characterization of influenza virus-induced death of J774.1 macrophages. Exp Cell Res 234:249-258, 1997
23. Lyon JA, Hinshaw VS: Replication of Influenza A viruses in an avian macrophage cell line. J Gen Virol 72 (Pt 8): 2011-2013, 1991
24. Mok CK, Lee DC, Cheung CY, Peiris M, Lau AS: Differential onset of apoptosis in Influenza A virus H5N1-and H1N1-infected human blood macrophages. J Gen Virol 88:1275-1280, 2007
25. Mukhopadhyay S, Hoidal JR, Mukherjee TK: Role of TNFalpha in pulmonary pathophysiology. Respir Res 7:125, 2006
26. Nain M, Hinder F, Gong JH, Schmidt A, Bender A, Sprenger H, Gemsa D: Tumor necrosis factor-alpha production of influenza A virus-infected macrophages and potentiating effect of lipopolysaccharides. J Immunol 145:1921-1928, 1990
27. Nickerson CL, Jakab GJ: Pulmonary antibacterial defenses during mild and severe influenza virus infection. Infect Immun 58:2809-2814, 1990
28. Payungporn S, Crawford PC, Kouo TS, Chen LM, Pompey J, Castleman WL, Dubovi EJ, Katz JM, Donis RO: Influenza A virus (H3N8) in dogs with respiratory disease, Florida. Emerg Infect Dis 14:902-908, 2008
29. Peeters D, Peters IR, Farnir F, Clercx C, Day MJ: Real-time RT-PCR quantification of mRNA encoding cytokines and chemokines in histologically normal canine nasal, bronchial and pulmonary tissue. Vet Immunol Immunopathol 104:195-204, 2005
30. Raabe MR, Issel CJ, Montelaro RC: Equine monocyte-derived macrophage cultures and their applications for infectivity and neutralization studies of equine infectious anemia virus. J Virol Methods 71:87-104, 1998
31. Reading PC, Miller JL, Anders EM: Involvement of the mannose receptor in infection of macrophages by influenza virus. J Virol 74:5190-5197, 2000
32. Rodgers B, Mims CA: Interaction of influenza virus with mouse macrophages. Infect Immun 31:751-757, 1981
33. Rodgers BC, Mims CA: Influenza virus replication in human alveolar macrophages. J Med Virol 9:177-184, 1982
34. Salentin R, Gemsa D, Sprenger H, Kaufmann A: Chemokine receptor expression and chemotactic responsiveness of human monocytes after influenza A virus infection. J Leukoc Biol 74:252-259, 2003
35. Scheid A, Choppin PW: Protease activation mutants of sendai virus: activation of biological properties by specific proteases. Virology 69:265-277, 1976
36. Seo SH, Webby R, Webster RG: No apoptotic deaths and different levels of inductions of inflammatory cytokines in alveolar macrophages infected with influenza viruses. Virology 329:270-279, 2004
37. Shaw SE, Anderson NV: Isolation and functional analysis of normal canine blood monocytes and resident alveolar macrophages. Am J Vet Res 45:87-90, 1984
38. Soergel SA, MacEwen EG, Vail DM, Potter DM, Sondel PM, Helfand SC: The immunotherapeutic potential of activated canine alveolar macrophages and antitumor monoclonal antibodies in metastatic canine melanoma. J Immunother 22:443-453, 1999
39. Steinhauser ML, Hogaboam CM, Kunkel SL, Lukacs NW, Strieter RM, Standiford TJ: IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense. J Immunol 162:392-399, 1999
40. Tumpey TM, Garcia-Sastre A, Taubenberger JK, Palese P, Swayne DE, Pantin-Jackwood MJ, Schultz-Cherry S, Solorzano A, Van Rooijen N, Katz JM, Basler CF: Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J Virol 79:14933-14944, 2005
41. van der Poll T, Marchant A, Keogh CV, Goldman M, Lowry SF: Interleukin-10 impairs host defense in murine pneumococcal pneumonia. J Infect Dis 174:994-1000, 1996
42. van der Sluijs KF, van Elden LJ, Nijhuis M, Schuurman R, Pater JM, Florquin S, Goldman M, Jansen HM, Lutter R, van der Poll T: IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection. J Immunol 172:7603-7609, 2004
43. Zell R, Krumbholz A, Eitner A, Krieg R, Halbhuber KJ, Wutzler P: Prevalence of PB1-F2 of influenza A viruses. J Gen Virol 88:536-546, 2007